Overview
QP-Breast MRI lesion detection, QP-Prostate FDA and CE-cleared prostate MRI AI, and quantitative imaging biomarker SaaS for hospitals and life sciences.
Product and company
Quibim — Medical Imaging is a verified product offering linked to the Brel Digital company profile for Quibim.
Use cases
QP-Breast MRI lesion detection, QP-Prostate FDA and CE-cleared prostate MRI AI, and quantitative imaging biomarker SaaS for hospitals and life sciences.
Target customer
Hospital radiology departments, breast MRI screening programs, life sciences oncology trials, and international imaging networks needing regulatory-cleared MRI AI.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://quibim.ai/newsroom/news-and-press-releases/quibim-launches-ce-and-ukca-marked-qp-breast-the-first-ai-tool-to-detect-breast-cancer-via-mri-in-europe-and-the-uk/
- Supporting source: https://quibim.ai/team/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- QP-Breast MRI lesion detection, QP-Prostate FDA and CE-cleared prostate MRI AI, and quantitative imaging biomarker SaaS for hospitals and life sciences.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.